Silexion Therapeutics (NASDAQ: SLXN)
$7.26
(-1.9%)
-$0.14
Price as of August 14, 2025, 2:12 p.m. ET
Silexion Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Silexion Therapeutics Company Info
Silexion Therapeutics Corp. engages in the discovery and development of treatments for KRAS-driven cancers. The company is headquartered in Modiin, Israel.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.